by Extivita | Mar 13, 2001 | Cancer
Abstract: Despite of improving diagnostics, development of new drugs and treatment strategies, patients with biologically unfavourable, advanced or relapsed neuroblastoma remain practically incurable. Treatment related toxicity, requirement for personnel and financial...
by Extivita | Dec 6, 2000 | Cancer
Abstract: Melbourne, Lehm, , , , , , , (2000). Quantifying the radiation exposure of nursing staff delivering hyperbaric oxygen therapy to grade IV neuroblastoma patients post 131I-MIBG therapy. European journal of nuclear medicine, 2000...
by Extivita | Mar 25, 2000 | Cancer
Abstract: Specific targeting of radionuclides to neuroblastoma, a neural crest tumour occurring predominantly in young children and associated with a relatively poor prognosis, may be achieved via the metabolic route (MIBG), receptor binding (peptides) or...
by Extivita | Mar 1, 1997 | Cancer
Abstract: Administration of a tumour-seeking compound labeled with a low-energy isotope and intraoperative screening with the gamma probe (radioguided surgery, RGS) could be useful in reoperations for advanced neuroblastoma when the normal anatomy is altered. A pilot...
by Extivita | Mar 1, 1997 | Cancer
Abstract: In this paper we report the effects of Hyperbaric Oxygen (HBO) exposure on the uptake and retention of meta-Iodobenzylguanidine (MIBG) in human platelets and two neuroendocrine cell lines. The combination of [131I] MIBG and HBO is used for therapy of...
